TL;DR

• Open-source tools like Selenium, Appium, and Playwright have no license fee, which is why they are the default starting point for most teams.
• The cost moves from the license to the total cost of ownership, the framework you build, the maintenance you carry, and the specialists you need.
• Commercial tools charge a license and absorb that work, with stable element identification, support, and faster time to productivity.
• The honest comparison is total cost of ownership over the life of the suite, not the sticker price at adoption.
• Honest caveat: open-source is the right call for teams with strong engineering capacity and a contained scope. The spend on a commercial tool is justified when maintenance and cross-technology coverage dominate.

Every test automation evaluation starts with the same instinct. Open-source tools are free, so why pay for a commercial one. It is a fair question, and the answer is not what the license line suggests. The license is the smallest part of what a test suite costs over its life. The real bill is the framework a team has to build around an open-source tool, the maintenance it carries release after release, and the specialist skill it takes to keep the whole thing running.

This comparison looks at total cost of ownership across the whole life of the suite. It covers what open-source and commercial tools actually cost, where each one fits, and how to run the numbers for your own team so the choice is made on the full cost and not the first line of it.

What do open-source test automation tools really cost?

Open-source test automation tools carry no license fee, and a real total cost of ownership that shows up elsewhere. Selenium, Appium, and Playwright give you an execution library, and you build everything around it, the framework, the reporting, the test data handling, and the CI integration. You maintain that framework as the tools and the application change, and you need engineers who can do that work. The cost did not disappear. It moved from a license line to engineering time.

Where the open-source cost actually lands

The total cost of ownership of an open-source tool lands in a few predictable places, and naming them is how you compare honestly against a commercial license. A team evaluating free tools should price each of these before calling the tool free.

The hidden costs:

• Framework build. Someone has to build the wrapper, the reporting, and the data handling the commercial tool ships with.
• Maintenance. Brittle locators break on UI changes, and keeping the suite green is ongoing engineering time.
• Specialist skill. The tool needs engineers who can code and maintain the framework, which is a hiring and retention cost.
• No vendor support. When something breaks, the team is its own support line, so a hard problem is your time to solve.
• Integration work. Cross-technology coverage, like desktop or SAP, often means stitching several tools together and maintaining the seams.

What a commercial tool charges for

A commercial tool charges a license and, in return, absorbs the work an open-source team does itself. The framework, the reporting, the data handling, and the integrations come built. Vendor support means a hard problem is someone else’s job to fix. And a well-built commercial tool reduces the maintenance that dominates the open-source bill, by identifying elements in a way that survives UI change instead of breaking on it. The license is a known, fixed number, and it buys down the variable engineering cost that open-source carries.

How to compare on total cost of ownership

Comparing these fairly means pricing the whole life of the suite, not the adoption moment. Put the license fee of the commercial tool on one side. On the other, put the engineering time to build and maintain an open-source framework, the specialist salaries it requires, the maintenance hours lost to brittle locators, and the integration work for any technology beyond the browser. Measured that way, the comparison often inverts, because the maintenance line grows every release while the license stays flat.

This is where Sahi Pro’s economics come from. The engine identifies elements by relationship and context, so tests survive UI changes that would break an open-source suite, which is the cleared 80 percent reduction in maintenance against conventional tools. Its single-flow architecture runs one script across web, desktop, mobile, SAP, and APIs, so cross-technology coverage is built in instead of stitched from several open-source tools. Teams reach productivity in about two weeks with no certification required, so the skill barrier and the ramp cost are lower than building an open-source framework from scratch.

Where open-source is the right call

Open-source is genuinely the right choice for some teams, and an honest comparison says so. A team with strong engineering capacity, a contained scope that stays in the browser, and the appetite to build and own a framework can get excellent results from Selenium or Playwright without a license. The commercial case gets stronger as the scope widens beyond the browser, as maintenance starts eating the team, and as the people who can maintain the framework become harder to hire. Match the tool to which of those describes your situation.

Compare the whole bill, not the license

Open-source test automation is free to license and carries a real total cost of ownership in framework, maintenance, and skill, while a commercial tool charges a license and absorbs that work. Compare the two on the full cost over the life of the suite, and let your engineering capacity and your scope decide. See how Sahi Pro’s maintenance and cross-technology coverage change the total cost against an open-source stack in a working session.

Sources

• From Fragile to Flow, Sahi Pro vs Selenium benchmark (maintenance effort 89 to 27, scenarios 23 to 144, regression maintenance cut 80 percent). Internal client asset.
• Cleared company-wide proof points: 80 percent lower maintenance vs conventional tools, teams productive in about two weeks with no certification required. Client facts.